Alkermes PLC
ALKS
ISIN IE00B56GVS15 / Valor 13920929
Alkermes PLC
UMushroom community rating:
About company
Alkermes PLC is a biopharmaceutical company focused on the development and commercialization of medicines for the treatment of psychiatric and neurological disorders, areas known for their complexity and the significant challenges they pose in treatment. Leveraging its deep expertise in neuroscience, Alkermes aims to address the unmet needs of patients suffering from conditions that are often difficult to treat and historically subject to stigma. The company's portfolio includes both marketed medicines and investigational drugs that are currently in various stages of clinical development. Alkermes emphasizes a patient-centric approach in its research and development efforts, striving to innovate in fields where therapeutic options are limited or inadequate. Through its integrated research strategy and specialized commercial infrastructure, Alkermes is committed to delivering new treatment options that can potentially transform the management of psychiatric and neurological diseases, underscoring its dedication to making a meaningful difference in patients' lives.
Summarized from source with an LLMView SourceSector: HealthcareKey figures
Performance
Volatility
4618 M
Market cap (USD)
2,320,759
Daily traded volume (Shares)
29.42 / 28.78
1 day high/low (USD)
52 weeks high/low (USD)
Dividend ex-date
Dividend (USD)
Dividend yield (p.a.)
Est dividend (USD)
Est dividend yield
P/E ratio
Est P/E ratio
EPS (USD)
Est EPS (USD)
Ratings & reviews
EQUITIES OF THE SAME SECTOR
